| abstract |
The present disclosure relates generally to the fields of immunology and molecular biology. More specifically, provided herein are pharmaceutical combinations comprising (A) antibodies,or antigen-binding portions thereof, directed against LY75, and (B) Venetoclax;methods for preparing pharmaceutical combinations;and methods for the treatment of diseases, such as cancers mediated by LY75expressionor activity. |